Cabrera-Salazar, M. A., DeRiso, M., Bercury, S. D., Li, L., Lydon, J. T., Weber, W., . . . Scheule, R. K. (2012). Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease. Public Library of Science.
Citação norma ChicagoCabrera-Salazar, Mario A., et al. Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease. Public Library of Science, 2012.
MLA citiranjeCabrera-Salazar, Mario A., et al. Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease. Public Library of Science, 2012.